CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
U TirelliE M Noordijk

Abstract

We report the results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group, which compared a chemotherapy regimen specifically devised for elderly patients, ie, etoposide, mitoxantrone, and prednimustine (VMP), versus the standard regimen of cyclophosphamide, doxorobucin, vincristine, and prednisone (CHOP) in patients older than 70 years of age with intermediate- and high-grade non-Hodgkin's lymphoma (NHL). Patients older than 70 years of age with stage II, III, or IV intermediate- and high-grade NHL, with an Eastern Cooperative Oncology Group (ECOG) performance status less than 4 and acceptable cardiac, renal, and liver function were randomized to receive six courses of VMP or six courses of CHOP. Between February 1989 and June 1994, 130 patients aged 70 to 93 years (median, 75) were enrolled and 120 were assessable for response, 60 patients in each arm. Overall objective response rates were 50% and 77% in VMP- and CHOP-treated patients, respectively (P = .01), while complete response (CR) rates were borderline significant (27% v 45%; P = .06). At 2 years, the progression-free survival (PFS) rate was 25% with VMP versus 55% with CHOP (P = .002) and the overall survival ...Continue Reading

Citations

Jul 8, 2000·The Oncologist·L Balducci, M Extermann
Apr 17, 2001·Current Opinion in Hematology·L BalducciG H Lyman
Nov 2, 2002·Journal of the American Geriatrics Society·Angel Segura HuertaRoberto Díaz
Nov 20, 2002·British Journal of Haematology·Ruth SonnenNorbert Schmitz
Nov 11, 2003·Clinical Pharmacokinetics·Hans WildiersAllan T van Oosterom
Jul 21, 2005·The British Journal of Dermatology·G Di LorenzoS De Placido
Apr 6, 2006·Internal Medicine·Naoto TomitaYoshiaki Ishigatsubo
Aug 19, 2008·Current Oncology Reports·Pieternella J Lugtenburg, Pieter Sonneveld
Mar 10, 2010·Drugs & Aging·Paolo F CaimiHillard M Lazarus
Jul 14, 2010·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Martine Extermann
Dec 4, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Gary H LymanLodovico Balducci
Aug 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J K DoorduijnP Sonneveld
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Dec 27, 2007·Cancer Biotherapy & Radiopharmaceuticals·Gerald L DeNardo
Nov 6, 2007·Cancer Biotherapy & Radiopharmaceuticals·Christos EmmanouilidesArturo Molina
Dec 7, 2007·Médecine sciences : M/S·Marie-Hélène Rodde Dunet, Anne Vitoux
Mar 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelvin K W ChanShabbir M H Alibhai
Jan 12, 2011·Journal of Cancer Research and Clinical Oncology·Yujin KobayashiJin Takeuchi
Nov 20, 1998·Hematological Oncology·U TirelliS Monfardini
Mar 29, 2000·Hospital Practice·L Balducci
Jul 15, 2000·Cancer Control : Journal of the Moffitt Cancer Center·L Balducci
Apr 12, 2003·Leukemia & Lymphoma·A D G KrolE M Noordijk
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine Thieblemont, Bertrand Coiffier

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.